ANTI-TUMOR NECROSIS FACTOR AGENTS

You have access
Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis
Carolina Birolo, Maria Elisabetta Zannin, Svetlana Arsenyeva, Rolando Cimaz, Elisabetta Miserocchi, Margarita Dubko, Chantal Job Deslandre, Fernanda Falcini, Maria Alessio, Francesco La Torre, Ekaterina Denisova, Giorgia Martini, Irina Nikishina and Francesco Zulian

The Journal of Rheumatology November 1 2016, 43 (11) 2068-2073; DOI: https://doi.org/10.3899/jrheum.151389
You have access
Hospitalizations of Patients Treated with Anti-Tumor Necrosis Factor-α Agents — A Retrospective Cohort Analysis
DEVY ZISMAN, AMIR HADDAD, SHARBEL HASHOUL, ARIE LAOR, HAIM BITTERMAN, ITZHAK ROSNER, LIHI EDER, ALEXANDRA BALBIR-GURMAN, REUVEN MADER and UZI MILMAN

The Journal of Rheumatology January 1 2013, 40 (1) 16-22; DOI: https://doi.org/10.3899/jrheum.111516
You have access
Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
MARIA E. ZANNIN, CAROLINA BIROLO, VALERIA M. GERLONI, ELISABETTA MISEROCCHI, IRENE PONTIKAKI, MARIA P. PAROLI, CLAUDIA BRACAGLIA, ALISON SHARDLOW, FULVIO PARENTIN, ROLANDO CIMAZ, GABRIELE SIMONINI, FERNANDA FALCINI, FABRIZIA CORONA, STEFANIA VIOLA, RICCARDO DE MARCO, LUCIANA BREDA, FRANCESCO LA TORRE, FABIO VITTADELLO, GIORGIA MARTINI and FRANCESCO ZULIAN

The Journal of Rheumatology January 1 2013, 40 (1) 74-79; DOI: https://doi.org/10.3899/jrheum.120583

Main menu

User menu

Search

ANTI-TUMOR NECROSIS FACTOR AGENTS

Content

Resources

Subscribers

More